Estradiol and Enterobacter infection - a phase IV clinical study of FDA data

Summary:

Enterobacter infection is reported only by a few people who take Estradiol.

The phase IV clinical study analyzes which people take Estradiol and have Enterobacter infection. It is created by eHealthMe based on reports of 6,092 people who have side effects while taking Estradiol from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jun, 25, 2022

6,092 people reported to have side effects when taking Estradiol.
Among them, 3 people (0.05%) have Enterobacter infection.

What is Estradiol?

Estradiol has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 7,358 Estradiol users for its effectiveness, alternative drugs and more.

What is Enterobacter infection?

Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae) is found to be associated with 672 drugs and 450 conditions by eHealthMe.

Number of Estradiol and Enterobacter infection reports submitted per year:

Could Estradiol cause Enterobacter infection?

Gender of people who have Enterobacter infection when taking Estradiol *:

female: 100 %
male: 0.0 %

Age of people who have Enterobacter infection when taking Estradiol *:

Common drugs people take besides Estradiol *:

Common side effects people have besides Enterobacter infection *:

Sinusitis (inflammation of sinus): 2 people, 66.67%
Haemophilus Infection (bacterial infection by haemophilus influenzae): 2 people, 66.67%
Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs): 2 people, 66.67%
Spinal Osteoarthritis (joint cartilage loss in spine): 1 person, 33.33%
Scab (a hard coating on the skin formed during the wound healing): 1 person, 33.33%
Osteoporosis (bones weak and more likely to break): 1 person, 33.33%
Multiple Fractures: 1 person, 33.33%
Inflammation: 1 person, 33.33%
Gout (uric acid crystals building up in the body): 1 person, 33.33%
Fever: 1 person, 33.33%

Common conditions people have *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 66.67%
Indigestion: 1 person, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 33.33%
Gastric Disorder (disease of stomach): 1 person, 33.33%
Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Estradiol and have Enterobacter infection?

Check whether Enterobacter infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Estradiol:

Estradiol (7,358 reports)

Enterobacter infection treatments and more:

Enterobacter infection (2,053 reports)

COVID vaccines that are related to Enterobacter infection:

How severe was Enterobacter infection and when was it recovered:

Enterobacter infection in Estradiol

Expand to all the drugs that have ingredients of estradiol:

Enterobacter infection and drugs with ingredients of estradiol

Common drugs associated with Enterobacter infection:

How the study uses the data?

The study uses data from the FDA. It is based on estradiol (the active ingredients of Estradiol) and Estradiol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.